References
- Gipson IK. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007;48(10):4390–4398. doi:https://doi.org/10.1167/iovs.07-0770.
- Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. March, 2001;45(Suppl 2):S203–S210. doi:https://doi.org/10.1016/S0039-6257(00)00203-4.
- Demirovic D, Rattan SIS. Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Exp Gerontol. 2013;48:94–98. doi:https://doi.org/10.1016/j.exger.2012.02.005.
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428‐435. doi:https://doi.org/10.1038/nature07201.
- Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:https://doi.org/10.1038/nri.2016.58.
- Di Zazzo A, Micera A, Coassin M, et al. Inflammaging at ocular surface: clinical and biomolecular analyses in healthy volunteers. Invest Ophthalmol Vis Sci. 2019;60(5):1769–1775. doi:https://doi.org/10.1167/iovs.18-25822.
- Rolando M, Refojo MF, Kenyon KR. Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol. 1983;101(4):557–558. doi:https://doi.org/10.1001/archopht.1983.01040010557003.
- Belmonte C. Pain, dryness, and itch sensations in eye surface disorders are defined by a balance between inflammation and sensory nerve injury. Cornea. 2019;38(Suppl 1):S11–S24. doi:https://doi.org/10.1097/ICO.0000000000002116.
- De Paiva CS, Pflugfelder SC. Tear clearance implications for ocular surface health. Exp Eye Res. 2004;78(3):395–397. doi:https://doi.org/10.1016/j.exer.2003.08.003.
- Barabino S, Montaldo E, Solignani F, Valente C, Mingari MC, Rolando M. Immune response in the conjunctival epithelium of patients with dry eye. Exp Eye Res. 2010;91:524–529. doi:https://doi.org/10.1016/j.exer.2010.07.008.
- Aragona P, Rolando M. Towards a dynamic customised therapy for ocularsurface dysfunctions. Br J Ophthalmol. August, 2013;97(8):955–960. doi:https://doi.org/10.1136/bjophthalmol-2012-302568.
- IASP (International Association for the Study of Pain) ‘s New Definition of Pain. 2017. https://www.iasp-pain.org.
- Lafreniere JD, Kelly MEM. Potential for endo-cannabinoid system modulation in ocular pain and inflammation: filling the gaps incurrent pharmacological options. Neuronal Signal. 2018;2. doi:https://doi.org/10.1042/NS20170144.
- Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15(3):404–437.
- International Association for the Study of Pain. IASP terminology. 2020. https://www.iasp-ain.org/Education/Content.aspx?ItemNumber=1698. updated December 14, 2017.
- Omoigui S. The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 – inflammatory profile of pain syndromes. Med Hypotheses. 2007;69(6):1169–1178. doi:https://doi.org/10.1016/j.mehy.2007.06.033.
- Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain. 2000;88(3):239–248. doi:https://doi.org/10.1016/S0304-3959(00)00331-6.
- Apfel SC. Neurotrophic factors and pain. Clin J Pain. 2000;16(2 Suppl):S7–11. doi:https://doi.org/10.1097/00002508-200006001-00003.
- Gould HJ 3rd, Gould TN, England JD, Paul D, Liu ZP, Levinson SR. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res. 2000;854(1–2):19–29. doi:https://doi.org/10.1016/S0006-8993(99)02216-7.
- Belmonte C, Acosta MC, Merayo-Lloves J, Gallar J. What causes eye pain? Curr Ophthalmol Rep. 2015;3(2):111–121. doi:https://doi.org/10.1007/s40135-015-0073-9.
- Rosenthal P, Borsook D. The corneal pain system. Part I: the missing piece of the dry eye puzzle. Ocul Surf. 2012;10:2–14. doi:https://doi.org/10.1016/j.jtos.2012.01.002.
- Parra A, Gonzalez-Gonzalez O, Gallar J, Belmonte C. Tear fluid hyperosmolality increases nerve impulse activity of cold thermoreceptor endings of the cornea. Pain. 2014;155(8):1481–1491. doi:https://doi.org/10.1016/j.pain.2014.04.025.
- Hirata H, Rosenblatt MI. Hyperosmolar tears enhance cooling sensitivity of the corneal nerves in rats: possible neural basis for cold-induced dry eye pain. Invest Ophthalmol Vis Sci. 2014;55(9):5821–5833. doi:https://doi.org/10.1167/iovs.14-14642.
- Galor A, Levitt R, Felix E, et al. Neuropathic ocular pain: an important yet under-evaluated feature of dry eye. Eye. 2015;29:301–312. doi:https://doi.org/10.1038/eye.2014.263.
- Bourcier T, Acosta MC, Borderie V, et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci. 2005;46(7):2341–2345. doi:https://doi.org/10.1167/iovs.04-1426.
- Chambers CT, Giesbrecht K, Craig KD, et al. A comparison of faces scales for the measurement of pediatric pain: children’s and parents’ ratings. Pain. 1999;83:25–35. doi:https://doi.org/10.1016/S0304-3959(99)00086-X.
- Chibnall JT, Tait RC. Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales. Pain. 2001;92:173–186. doi:https://doi.org/10.1016/S0304-3959(00)00485-1.
- Jensen MP, Karoly P, O’Riordan EF, et al. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989;5:153–159. doi:https://doi.org/10.1097/00002508-198906000-00005.
- Closs SJ, Barr B, Briggs M, et al. A comparison of five pain assessment scales for nursing home residents with varying degrees of cognitive impairment. J Pain Symptom Manage. 2004;27:196–205. doi:https://doi.org/10.1016/j.jpainsymman.2003.12.010.
- Qazi Y, Hurwitz S, Khan S, Jurkunas UV, Dana R, Hamrah P. Validity and reliability of a novel ocular pain assessment survey (OPAS) in quantifying and monitoring corneal and ocular surface pain. Ophthalmology. 2016;123(7):1458–1468. doi:https://doi.org/10.1016/j.ophtha.2016.03.006.
- Crawford B, Bouhassira D, Wong A, Dukes E. Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes. 2008;6:62. doi:https://doi.org/10.1186/1477-7525-6-62.
- Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108:248–257. doi:https://doi.org/10.1016/j.pain.2003.12.024.
- Galor A. Painful dry eye symptoms: a nerve problem or a tear problem? Ophthalmology. 2019;126:5. doi:https://doi.org/10.1016/j.ophtha.2019.01.028.
- Efron N, Brennan NA, Hore J, Rieper K. Temperature of the hyperemic bulbar conjunctiva. Eur J Ophthalmol. 2015;25(4):273–279. doi:https://doi.org/10.5301/ejo.5000626.
- McMonnies CW, Chapman-Davies A. Assessment of conjunctival hyperemia in contact lens wearers. Part I. Am J Optom Physiol Opt. 1987;64(4):246–250. doi:https://doi.org/10.1097/00006324-198704000-00003.
- Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt. 2001;21:17–29.
- Schulze MM, Jones DA, Simpson TL. The development of validated bulbar redness grading scales. Optom Vis Sci. 2007;84:976–983. doi:https://doi.org/10.1097/OPX.0b013e318157ac9e.
- Ohta K, Wiggert B, Taylor AW, Streilein JW. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci. 1999;40:2010–2018.
- Fieguth P, Simpson TL. Automated measurement of bulbar redness. Invest Ophthalmol Vis Sci. 2002;43:340–347.
- Yoneda T, Sumi T, Takahashi A, Hoshikawa Y, Kobayasih M, Fukushima A. Automated hyperemia analysis software: reliability and reproducibility in healthy subjects. Jpn J Ophthalmol. 2012;56:1–7. doi:https://doi.org/10.1007/s10384-011-0107-2.
- Wu S, Hong J, Tian L, Cui X, Sun X, Xu J. Assessment of bulbar redness with a newly developed keratograph. Optom Vis Sci. 2015;92(8):892–899. doi:https://doi.org/10.1097/OPX.0000000000000643.
- Danjo Y, Watanabe H, Tisdale A, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998;39:2602–2609.
- Baudouin C, Rolando M, Benitez Del Castillo JM, et al. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog Retin Eye Res. 2019;71:68–87. doi:https://doi.org/10.1016/j.preteyeres.2018.11.007.
- Tai EK, Wong HP, Lam EK, et al. Cathelicidin stimulates colonic mucus synthesis by upregulating MUC1 and MUC2 expression through a mitogenactivated protein kinase pathway. J Cell Biochem. 2008;104:251–258. doi:https://doi.org/10.1002/jcb.21615.
- Shatos MA, Gu J, Hodges RR, Lashkari K, Dartt DA. ERK/p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet cells in culture. Invest Ophthalmol Vis Sci. 2008;49(8):3351–3359. doi:https://doi.org/10.1167/iovs.08-1677.
- Argüeso P, Tisdale A, Mandel U, et al. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci. 2003;44:86–92. doi:https://doi.org/10.1167/iovs.02-0181.
- He M, Lippestad M, Li D, Hodges RR, Utheim TP, Dartt DA. Activation of the EGF receptor by histamine receptor subtypes stimulates mucin secretion in conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2018;59:3543–3553. doi:https://doi.org/10.1167/iovs.18-2476.
- Kanno H, Horikawa Y, Hodges RR, et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol. 2003;284:C988–C998. doi:https://doi.org/10.1152/ajpcell.00582.2001.
- Dartt DA, Hodges RR, Li D, et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol. 2011;186:4455–4466. doi:https://doi.org/10.4049/jimmunol.1000833.
- Li D, Jiao J, Shatos MA, Hodges RR, Dartt DA. Effect of VIP on intracellular [Ca2.], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2013;54:2872–2884. doi:https://doi.org/10.1167/iovs.12-11264.
- Rios JD, Zoukhri D, Rawe IM, et al. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest Ophthalmol Vis Sci. 1999;40:1102–1111.
- Dartt DA, Kessler TL, Chung EH, et al. Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. Exp Eye Res. 1996;63:27–34. doi:https://doi.org/10.1006/exer.1996.0088.
- Gipson IK, Spurr-Michaud SJ, Senchyna M, Ritter R 3rd, Schaumberg D. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea. 2011;30(12):1346–1352. doi:https://doi.org/10.1097/ICO.0b013e31820d852a.
- Rolando M, Terragna F, Giordano G, Calabria G. Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica. 1990;200(4):170–176. doi:https://doi.org/10.1159/000310101.
- Hayashi Y, Kao WW, Kohno N, et al. Expression patterns of sialylated epitope recognized by KL-6 monoclonal antibody in ocular surface epithelium of normals and dry eye patients. Invest Ophthalmol Vis Sci. 2004;45:2212–2217. doi:https://doi.org/10.1167/iovs.03-0988.
- Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, et al. Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res. 2010;90:444–451. doi:https://doi.org/10.1016/j.exer.2009.12.009.
- Blalock TD, Spurr-Michaud SJ, Tisdale AS, et al. Release of membrane-associated mucins from ocular surface epithelia. Invest Ophthalmol Vis Sci. 2008;49:1864–1871. doi:https://doi.org/10.1167/iovs.07-1081.
- Tanioka H, Yokoi N, Komuro A, et al. Investigation of the corneal filament in filamentary keratitis. Invest Ophthalmol Vis Sci. 2009;50:3696–3702. doi:https://doi.org/10.1167/iovs.08-2938.
- Versura P, Maltarello MC, Cellini M, et al. Detection of mucus glycoconjugates in human conjunctiva by using the lectin-colloidal gold technique in TEM. II. A quantitative study in dry-eye patients. Acta Opthalmol (Copenh). 1986;64:451–455. doi:https://doi.org/10.1111/j.1755-3768.1986.tb06952.x.
- Mantelli F, Argüeso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8(5):477–483. doi:https://doi.org/10.1097/ACI.0b013e32830e6b04.
- Yang S, Lee HJ, Kim DY, Shin S, Barabino S, Chung SH. The use of conjunctival staining to measure ocular surface inflammation in patients with dry eye. Cornea. 2019;38:698–705. doi:https://doi.org/10.1097/ICO.0000000000001916.
- Barabino S, Valente C, Montaldo E, Mingari MC, Rolando M, Traverso CE. Does lissamine green staining of the ocular surface correlate with inflammation in dry eye patients? Invest Ophthalmol Vis Sci. 2012;53:E–Abstract546.
- Hamrah P, Alipour F, Jiang S, Sohn J-H, Foulks GN. Optimizing evaluation of Lissamine Green parameters for ocular surface staining. Eye. 2011;25(11):1429–1434. doi:https://doi.org/10.1038/eye.2011.184.
- Potvin R, Makari S, Rapuano CJ. Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol. 2015;9:2039–2047. doi:https://doi.org/10.2147/OPTH.S95242.